News
![EQS-News: Knorr-Bremse Acquires Alstom’s Rail Signalling Technology Business in North America](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
EQS-News: Knorr-Bremse Acquires Alstom’s Rail Signalling Technology Business in North America
EQS-News: Knorr-Bremse Acquires Alstom’s Rail Signalling Technology Business in North America
![EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Signs Agreement on the Acquisition of Alstom’s Rail Signalling Technology Business in North America](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Signs Agreement on the Acquisition of Alstom’s Rail Signalling Technology Business in North America
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Signs Agreement on the Acquisition of Alstom’s Rail Signalling Technology Business in North America
![EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
![EQS-News: Knorr-Bremse Plans to Raise Dividend by a Significant 13% to € 1.64](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
EQS-News: Knorr-Bremse Plans to Raise Dividend by a Significant 13% to € 1.64
EQS-News: Knorr-Bremse Plans to Raise Dividend by a Significant 13% to € 1.64
![EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
![EQS-News: Knorr-Bremse Aktiengesellschaft: Record Year for Knorr-Bremse: Revenues, Order Intake, and Order Book at Historic Highs, Turnaround Achieved, EBIT Margin Risen](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Record Year for Knorr-Bremse: Revenues, Order Intake, and Order Book at Historic Highs, Turnaround Achieved, EBIT Margin Risen
EQS-News: Knorr-Bremse Aktiengesellschaft: Record Year for Knorr-Bremse: Revenues, Order Intake, and Order Book at Historic Highs, Turnaround Achieved, EBIT Margin Risen
![EQS-News: Knorr-Bremse sells Kiepe Electric to Heramba](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
EQS-News: Knorr-Bremse sells Kiepe Electric to Heramba
EQS-News: Knorr-Bremse sells Kiepe Electric to Heramba
![EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives
EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives
![EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share
EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share
![EQS-News: Dermapharm Holding SE builds on success in Q3 2023](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
![EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
![EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow
![EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
![EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business
EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business
![EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
![EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
![EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Strong Growth in Revenues and Profit in H1 2023](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Strong Growth in Revenues and Profit in H1 2023
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Strong Growth in Revenues and Profit in H1 2023
![EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit
EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit
![EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Lays Groundwork for the Future: Global Strategy Update “Next Level” with Strong Focus on Profitable Growth](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Lays Groundwork for the Future: Global Strategy Update “Next Level” with Strong Focus on Profitable Growth
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Lays Groundwork for the Future: Global Strategy Update “Next Level” with Strong Focus on Profitable Growth
![EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
![EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
![EQS-Adhoc: DWS Group GmbH & Co. KGaA: CFO Claire Peel to leave in late Q3 2023](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
EQS-Adhoc: DWS Group GmbH & Co. KGaA: CFO Claire Peel to leave in late Q3 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: CFO Claire Peel to leave in late Q3 2023
![EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
![EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Starts with Increased Profits into 2023](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Starts with Increased Profits into 2023
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Starts with Increased Profits into 2023
![EQS-News: Knorr-Bremse Aktiengesellschaft: Dividend of € 1.45 approved at Annual General Meeting](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Dividend of € 1.45 approved at Annual General Meeting
EQS-News: Knorr-Bremse Aktiengesellschaft: Dividend of € 1.45 approved at Annual General Meeting